Europos Sąjunga - ispanų - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Europos Sąjunga - ispanų - EMA (European Medicines Agency)

roche registration gmbh - pertuzumab, trastuzumab - neoplasias de la mama - agentes antineoplásicos - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.

Europos Sąjunga - ispanų - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacunas - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Europos Sąjunga - ispanų - EMA (European Medicines Agency)

billev pharma aps - lutetium (177lu) chloride - imágenes de radionúclidos - radiofármacos terapéuticos - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Europos Sąjunga - ispanų - EMA (European Medicines Agency)

curium pet france - piflufolastat (18f) - neoplasmas prostáticos - radiofármacos de diagnóstico - este medicamento es solo para uso diagnóstico. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).

Čilė - ispanų - ISPC (Instituto de Salud Pública de Chile)

laboratorio internacional de cosmÉticos s.a. - sin formulas

Europos Sąjunga - ispanų - EMA (European Medicines Agency)

zoetis belgium sa - virus de la lengua azul inactivado, serotipo-1 - inmunológicos - oveja - inmunización activa de ovejas desde 1. 5 meses de edad para la prevención de la viremia causada por el virus de la lengua azul, serotipos-1. inicio de la inmunidad: 21 días después de la finalización del esquema de vacunación primaria. duración de la inmunidad: 12 meses.

Peru - ispanų - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

mg natura s.a.c. - capsula

Čilė - ispanų - ISPC (Instituto de Salud Pública de Chile)

cela cosmÉticos s.a. - sin formulas

Čilė - ispanų - ISPC (Instituto de Salud Pública de Chile)

cela cosmÉticos s.a. - sin formulas